Barrett's esophagus: proton pump inhibitors and chemoprevention II Journal Articles

abstract

• The following on proton pump inhibitors (PPIs) and chemoprevention in relation to Barrett's esophagus includes commentaries on 48‐h pH monitoring, pH‐impedence, bile acid testing, dyspepsia, long/short segment Barrett's esophagus, nonerosive reflux disease (NERD), functional heartburn, dual‐release delivery PPIs, immediate‐release PPIs, long‐term PPI use, prokinetic agents, obesity, baclofen, nocturnal acid breakthrough, nonsteroidal anti‐inflammatory drugs (NSAIDs), and new PPIs.

authors

• Richter, Joel E
• Penagini, Roberto
• Pohl, Daniel
• Dvorak, Katerina
• Goldman, Aaron
• Savarino, Edoardo
• Zentilin, Patrizia
• Savarino, Vincenzo
• Watson, Joshua T
• Wong, Roy KH
• Pace, Fabio
• Casini, Valentina
• Peura, David A
• Herzig, Shoshana Joy
• Kamiya, Takeshi
• Pelosini, Iva
• Scarpignato, Carmelo
• Armstrong, David
• DeVault, Kenneth R
• Bechi, Paolo
• Taddei, Antonio
• Freschi, Giancarlo
• Ringressi, Maria Novella
• Degli'Innocenti, Duccio Rossi
• Castiglione, Francesca
• Masini, Emmanuella
• Hunt, Richard

status

• published 

publication date

• September 2011

has subject area

• Barrett Esophagus (MeSH)
• Chemoprevention (MeSH)
• General Science & Technology (Science Metrix)
• Humans (MeSH)
• Monitoring, Physiologic (MeSH)
• Proton Pump Inhibitors (MeSH)
• Treatment Outcome (MeSH)

published in

• Annals of the New York Academy of Sciences  Journal

keywords

• Barrett Esophagus
• Chemoprevention
• Humans
• Monitoring, Physiologic
• Proton Pump Inhibitors
• Treatment Outcome

Digital Object Identifier (DOI)

• 10.1111/j.1749-6632.2011.06048.x

PubMed ID

• 21950810

start page

• 114

end page

• 139

volume

• 1232

issue

• 1